Daynamica was co-developed by Associate Professor Julian Wolfson and captures detailed activity and travel information when people are driving, walking, biking, or using mass transit, such as riding a bus.
Biostatistics PhD student Roland Brown and recent graduate Chong Wu (PhD ‘18) won ENAR Distinguished Student Paper Awards, receiving a travel stipend to present their research at the ENAR Spring Meeting held March 24-27 in Philadelphia.
Assistant Professor Eric Lock has received a $1-million grant from the NIH to develop new methods to analyze multi-source and multi-way data all together at the same time.
Assistant Professor David Vock has been named a McKnight Presidential Fellow, a three-year award given to promising faculty members based on their research, scholarship, leadership, and ability to advance University of Minnesota priorities.
Research co-led by Professor Cavan Reilly shows Ebola survivors suffer from a range of health problems including body pain, eye conditions, and memory loss.
Faculty Joe Koopmeiners and David Vock will apply their methodology to data from 12 randomized trials of reduced-nicotine cigarettes to evaluate the impact of nicotine reduction as a regulatory policy.
SPH’s Coordinating Centers for Biometric Research leads global clinical trials to prevent and treat disease.
Lecturer Marta Shore helped perform research that shows how sulfate from wastewater harms Minnesota’s wild rice habitats.
Professor John Connett is a researcher on a new $14 million study examining non-drug approaches to prevent chronic low back pain.
Connor Jo Lewis discovers the field of biostatistics through a love of math and a drive to end cystic fibrosis, a disease she was diagnosed with as a child.
Associate Professor Saonli Basu and Professor Cavan Reilly have been named 2017 Fellows of the American Statistical Association.
A study by Assistant Professor Julian Wolfson tested two popular cardiovascular risk calculators using patient electronic health data and found that they maintain their accuracy at predicting cardiovascular risk when they are used in a clinical setting.